Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural changes in cardiovascular disease

J N Cohn1

  • 1Department of Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.

The American Journal of Cardiology
|November 24, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.

Journal of human hypertension·2012
Same author

Rationale for angiotensin II receptor blocker therapy in chronic heart failure.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2007
Same author

Relationship between C-reactive protein and arterial stiffness in an asymptomatic population.

Journal of human hypertension·2005
Same author

Angiotensin receptor blockers and clinical trials in heart failure.

European heart journal·2003
Same author

Small and large artery elasticity indices in peripheral arterial occlusive disease (PAOD).

Vascular medicine (London, England)·2002
Same author

Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination.

Congestive heart failure (Greenwich, Conn.)·2002
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Structural changes in the heart and blood vessels are key to cardiovascular disease. Angiotensin-converting enzyme (ACE) inhibitors show promise in altering disease progression by targeting these remodeling processes.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Structural alterations in the heart and vasculature are a common pathway for cardiovascular disease morbidity and mortality.
  • Current therapeutic strategies are increasingly focusing on these structural changes.

Purpose of the Study:

  • To explore the role of interventions, particularly angiotensin-converting enzyme (ACE) inhibitors, in modifying cardiovascular remodeling.
  • To highlight the importance of addressing structural abnormalities in chronic cardiovascular diseases.

Main Methods:

  • Review of existing literature on the effects of ACE inhibitors on left ventricular and vascular remodeling.
  • Discussion of potential mechanisms of action for ACE inhibitors, including effects on angiotensin II and bradykinin.
  • Exploration of other agents that may complement ACE inhibitor actions.

Related Experiment Videos

Main Results:

  • ACE inhibitors demonstrate a significant effect on both left ventricular and vascular remodeling.
  • The precise mechanisms by which ACE inhibitors exert their effects (e.g., angiotensin II reduction, bradykinin increase) require further elucidation.
  • Other therapeutic agents may also play a role in inhibiting adverse remodeling processes.

Conclusions:

  • Future therapies for chronic cardiovascular diseases must prioritize structural abnormalities.
  • Targeted interventions aimed at specific structural changes hold potential to profoundly impact disease outcomes.
  • ACE inhibitors represent a promising class of drugs for altering the natural history of cardiovascular diseases by targeting remodeling.